Global Health Centre
Marcela Vieira

Non-commercial pharmaceutical R&D: What do PDPs suggest about costs and efficiency?

Marcela Vieira
, -

Knowledge Network for Innovation and Access to Medicines

Webinar:  4pm CET

Add to Calendar

There is growing interest in alternate "business models" of R&D as potential solutions to some of the shortcomings of the current R&D system -- namely, high prices, unmet innovation needs in certain areas, and limited availability. There has been significant experimentation in alternate business models for neglected diseases (ND) with the creation of over 20 Product Development Partnerships (PDPs) and about two decades of experience now available. PDPs have demonstrated the feasibility of developing new medicines through non-commercial approaches, but understanding has been limited of how they compare to commercial R&D. Marcela Vieira will present a recently published study analysing data on the costs and efficiency of PDPs compared to estimates from commercial R&D, and exploring similarities and differences between the two business models.



  • Marcela Vieira, Researcher and Project Coordinator of the Knowledge Network for Innovation and Access to Medicines, Global Health Centre
  • Moderator: Suerie Moon, Co-Director, Global Health Centre

Event Materials

Knowledge Network for Innovation and Access to Medicines